Earnings History Data for Adamis Pharmaceuticals Corporation (ADMP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
15-05-2023 AH 4:10 PM ET
(May 15)		 ADMP Adamis Pharmaceuticals Corporation 13.32 -0.06 0.00 -0.07 Adamis Pharmaceuticals GAAP EPS of -$0.06, revenue of $1.45M
[5/15/2023 4:51 PM]		 0.0695 0.0 
(-0.71%)		 0.07 0.0 
(0.14%)		 0.06 - 0.55 2,154,568 1,630,000 52,135
16-03-2023 AH 4:10 PM ET
(Mar 16)		 ADMP Adamis Pharmaceuticals Corporation 41.65 N/A 0.00 0.00 Adamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75M
[3/16/2023 4:32 PM]		 0.1098 -0.01 
(-9.11%)		 0.13 0.01 
(4.30%)		 0.11 - 0.68 2,225,229 1,750,000 46,954
14-11-2022 AH 4:00 PM ET
(Nov 14)		 ADMP Adamis Pharmaceuticals Corporation 22.41 -0.03 0.00 -0.03 Adamis Pharmaceuticals GAAP EPS of -$0.03, revenue of $1.51M
[11/14/2022 6:36 PM]		 0.21 0.03 
(16.67%)		 0.18 0.0 
(-0.11%)		 0.12 - 1.08 2,385,463 750,000 28,958
10-08-2022 AH 4:35 PM ET
(Aug 10)		 ADMP Adamis Pharmaceuticals Corporation 59.69 -0.06 -0.04 0.00 Adamis Pharmaceuticals GAAP EPS of -$0.06 misses by $0.02, revenue of $0.04M misses by $0.36M
[8/10/2022 4:06 PM]		 0.3459 -0.03 
(-6.77%)		 0.36 -0.01 
(-2.99%)		 0.31 - 1.48 2,055,759 690,000 14,027
16-05-2022 AH 4:45 PM ET
(May 16)		 ADMP Adamis Pharmaceuticals Corporation 52.44 -0.07 -0.03 0.00 Adamis Pharmaceuticals reports Q1 results
[5/16/2022 4:40 PM]		 0.4274 -0.04 
(-8.01%)		 0.42 -0.05 
(-10.25%)		 0.31 - 1.48 928,698 720,000 6,694
31-03-2022 AH 4:45 PM ET
(Mar 31)		 ADMP Adamis Pharmaceuticals Corporation 87.10 N/A -0.04 -0.16 Adamis Pharmaceuticals reports Q4 results
[3/31/2022 4:57 PM]		 0.57 0.0 
(-0.18%)		 0.58 0.01 
(1.94%)		 0.52 - 1.48 1,006,539 970,000 27,245
15-04-2021 AH 4:30 PM ET
(Apr 15)		 ADMP Adamis Pharmaceuticals Corporation 109.00 -0.16 -0.06 0.00 Adamis Pharmaceuticals misses on revenue
[4/15/2021 4:55 PM]		 0.7339 0.0 
(-0.50%)		 0.74 0.0 
(0.39%)		 0.32 - 2.34 3,787,836 3,040,000 28,677
09-11-2020 AH 4:40 PM ET
(Nov 9)		 ADMP Adamis Pharmaceuticals Corporation 65.55 -0.10 -0.04 -0.11 Adamis Pharmaceuticals EPS misses by $0.01, misses on revenue
[11/9/2020 4:39 PM]		 0.6895 -0.03 
(-3.57%)		 0.7180 0.0 
(0.42%)		 0.27 - 1.51 3,253,281 3,271,525 90,023